Implications for R&D and knowledge transfer in pharmaceutical companies after the acquisition of a biotech company

Schweizer, LarsLarsSchweizer2019-09-192014-09-242004https://fis.uni-bamberg.de/handle/uniba/12991engImplications for R&D and knowledge transfer in pharmaceutical companies after the acquisition of a biotech companyconferenceobject